Skip to content

Clinical trials

Diabetic Neuropathies trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Country / region: Mexico Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20072
20082
20102
20111
20121
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie (prior sponsor, Abbott)2
Eli Lilly and Company2
Sangamo Therapeutics2
Alejandra Guillermina Miranda Diaz1
Anahuac University1
Hospital Universitario Dr. Jose E. Gonzalez1
Instituto Mexicano del Seguro Social1
Maria Gabriela Aké Palomo1
Merck KGaA, Darmstadt, Germany1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies14
Diabetes Mellitus, Type 23
Neuralgia3
Diabetes Mellitus, Type 12
Pain2
Diabetes Mellitus1
Hereditary Sensory and Autonomic Neuropathies1
Mitochondrial Diseases1
Mononeuropathies1
Polyneuropathies1

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.